CMG Pharmaceutical Co. Ltd Capital Reinvestment Ratio
CMG Pharmaceutical Co. Ltd capital reinvestment ratio. CMG Pharmaceutical Co. Ltd (058820) has a Capital Reinvestment Ratio of 109.44x as of December 2024, meaning it reinvests 109% of its operating cash flow (₩290.09 Million) in capital expenditures (₩31.75 Billion). Check CMG Pharmaceutical Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CMG Pharmaceutical Co. Ltd (2014–2024)
Capital reinvestment ratio of CMG Pharmaceutical Co. Ltd from 2014 to 2024. This chart tracks CMG Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore 058820 net assets growth trend to track the company's year-over-year net asset growth rate.
CMG Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2014–2024)
CMG Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see 058820 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 109.44x | ₩290.09 Million | ₩31.75 Billion | ▲ +2706.1% |
| 2023 | 3.90x | ₩3.91 Billion | ₩15.25 Billion | ▲ +86.8% |
| 2022 | 2.09x | ₩4.94 Billion | ₩10.31 Billion | ▲ +197.4% |
| 2021 | 0.70x | ₩5.63 Billion | ₩3.95 Billion | ▼ -78.6% |
| 2020 | 3.28x | ₩2.94 Billion | ₩9.65 Billion | ▲ +13.2% |
| 2019 | 2.90x | ₩2.82 Billion | ₩8.18 Billion | ▲ +0.9% |
| 2018 | 2.87x | ₩886.78 Million | ₩2.55 Billion | ▲ +635.3% |
| 2017 | 0.39x | ₩1.95 Billion | ₩760.59 Million | ▲ +12.8% |
| 2016 | 0.35x | ₩2.31 Billion | ₩799.00 Million | ▼ -77.0% |
| 2015 | 1.51x | ₩2.41 Billion | ₩3.64 Billion | ▼ -88.4% |
| 2014 | 13.00x | ₩724.89 Million | ₩9.42 Billion | — |